Baidu
map

新常青藤联盟接力ACE试验 糖尿病预防从餐后血糖开始

2017-09-27 李惠钰 科学网

拜耳医药保健有限公司“ACE研究结果中国发布会”在京召开,会上同时启动“新常青藤联盟”,以餐后血糖筛查为出发点,推动中国糖尿病的预防工作。

新常青藤联盟成立仪式现场


日前,拜耳医药保健有限公司“ACE研究结果中国发布会”在京召开,会上同时启动“新常青藤联盟”,以餐后血糖筛查为出发点,推动中国糖尿病预防工作。

ACE于2008年正式启动,是迄今为止规模最大的中国糖尿病前期干预研究。在第53届欧洲糖尿病研究协会年会上公布的ACE研究结果显示,冠心病合并糖耐量减低的中国患者在按照指南推荐进行生活方式干预的基础上,接受口服降糖药“拜唐苹”(阿卡波糖)治疗能够显著降低新发糖尿病风险,同时拜唐苹也展现出了极佳的安全性。

“ACE为中国糖尿病预防增添了新的力证,开启了中国糖尿病预防的新时代。”ACE研究联合主席、北京大学人民医院教授胡大一表示,ACE研究结果提示糖尿病前期人群及早接受积极的生活方式或药物干预,能够有效预防糖尿病,从而降低糖尿病并发症发生风险。

与此同时,中日友好医院教授杨文英强调,在糖尿病前期和早期阶段,糖尿病“三多一少”的典型症状表现往往并不明显,常规体检只检测空腹血糖不查餐后血糖,将有一半的糖尿病和70%的糖尿病前期被漏诊。

中国糖尿病及糖尿病前期最新流行病学数据显示,2013年中国成人糖尿病患病率为10.9%,糖尿病前期流行率达35.7%,其中70%的人群是以餐后血糖升高为主。

为此,新常青藤联盟接力ACE试验,从治疗到预防,直面糖尿病预防和早期干预的核心挑战——单纯餐后血糖升高的糖尿病和糖耐量异常早期筛查与早期干预,针对常规体检仅测空腹血糖不查餐后血糖造成的大量糖尿病与糖尿病前期漏诊,联合医院、社区医疗机构、商业体检中心、基金会及媒体等多方面力量,推动将餐后血糖纳入体检以及糖尿病筛查流程,从根本上提高糖尿病和糖尿病前期的早期诊断率,及时干预,最大限度降低糖尿病及其并发症的发生风险。

“新常青藤联盟”还将联合社会各界力量,以餐后血糖筛查为出发点,推动中国糖尿病的预防工作。联盟将与公立医院合作,将口服葡萄糖耐量试验逐渐纳入糖尿病高危人群体检的标准流程;在商业体检中心,对体检空腹血糖大于5.6的患者在体检报告上给予提醒,建议检测餐后血糖;在心内科病房和门诊,推动冠心病和高血压等心血管疾病患者的餐后血糖筛查和管理;在社区卫生服务中心,推动《中国糖尿病风险评估量表》的使用以及高危人群的餐后血糖筛查,从真正意义上实现早筛查、早干预。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2045476, encodeId=a31320454e6af, content=<a href='/topic/show?id=a982e680663' target=_blank style='color:#2F92EE;'>#糖尿病预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76806, encryptionId=a982e680663, topicName=糖尿病预防)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Mon Apr 02 12:00:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655800, encodeId=8273165580026, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Mon Mar 26 01:00:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488454, encodeId=8b2514884541a, content=<a href='/topic/show?id=019e1011e589' target=_blank style='color:#2F92EE;'>#餐后血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101175, encryptionId=019e1011e589, topicName=餐后血糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76df8418429, createdName=gjsgj, createdTime=Fri Sep 29 12:00:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496595, encodeId=91a41496595f4, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Fri Sep 29 12:00:00 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2045476, encodeId=a31320454e6af, content=<a href='/topic/show?id=a982e680663' target=_blank style='color:#2F92EE;'>#糖尿病预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76806, encryptionId=a982e680663, topicName=糖尿病预防)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Mon Apr 02 12:00:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655800, encodeId=8273165580026, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Mon Mar 26 01:00:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488454, encodeId=8b2514884541a, content=<a href='/topic/show?id=019e1011e589' target=_blank style='color:#2F92EE;'>#餐后血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101175, encryptionId=019e1011e589, topicName=餐后血糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76df8418429, createdName=gjsgj, createdTime=Fri Sep 29 12:00:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496595, encodeId=91a41496595f4, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Fri Sep 29 12:00:00 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
    2018-03-26 shanyongle
  3. [GetPortalCommentsPageByObjectIdResponse(id=2045476, encodeId=a31320454e6af, content=<a href='/topic/show?id=a982e680663' target=_blank style='color:#2F92EE;'>#糖尿病预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76806, encryptionId=a982e680663, topicName=糖尿病预防)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Mon Apr 02 12:00:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655800, encodeId=8273165580026, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Mon Mar 26 01:00:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488454, encodeId=8b2514884541a, content=<a href='/topic/show?id=019e1011e589' target=_blank style='color:#2F92EE;'>#餐后血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101175, encryptionId=019e1011e589, topicName=餐后血糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76df8418429, createdName=gjsgj, createdTime=Fri Sep 29 12:00:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496595, encodeId=91a41496595f4, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Fri Sep 29 12:00:00 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2045476, encodeId=a31320454e6af, content=<a href='/topic/show?id=a982e680663' target=_blank style='color:#2F92EE;'>#糖尿病预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76806, encryptionId=a982e680663, topicName=糖尿病预防)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Mon Apr 02 12:00:00 CST 2018, time=2018-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655800, encodeId=8273165580026, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Mon Mar 26 01:00:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488454, encodeId=8b2514884541a, content=<a href='/topic/show?id=019e1011e589' target=_blank style='color:#2F92EE;'>#餐后血糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101175, encryptionId=019e1011e589, topicName=餐后血糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76df8418429, createdName=gjsgj, createdTime=Fri Sep 29 12:00:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496595, encodeId=91a41496595f4, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Fri Sep 29 12:00:00 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
    2017-09-29 zexyw04

相关资讯

JCEM:非HLA基因单核苷酸多态性有助于1型糖尿病预防试验的风险分层(TrialNet研究)

背景:近年来,全基因组关联研究中超过50个研究确定了非HLA基因单核苷酸多态性与1型糖尿病相关。目的:本研究的目的是评估非HLA基因单核苷酸多态性(SNP)对疾病进展风险的作用。研究设计与设置:TrialNet途径预防研究中1型糖尿病患者的自身抗体(Ab) 和1型糖尿病的发展。参与者:利用免疫芯片,研究人员在1061名自身抗体阳性的非西班牙裔白人中分析了53个与糖尿病的风险有关的非HLA基因单核苷

Baidu
map
Baidu
map
Baidu
map